Definitive Healthcare Corp. DH
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About DH
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Definitive Healthcare Corp. is a U.S.-based healthcare commercial intelligence and data analytics company that provides data, analytics, and workflow tools to organizations operating across the healthcare ecosystem. The company primarily serves pharmaceutical manufacturers, medical device companies, healthcare providers, health insurers, consulting firms, and healthcare technology vendors. Its platform aggregates and analyzes healthcare provider, claims, prescription, and market intelligence data to support sales targeting, market research, care coordination, and commercial strategy. Definitive Healthcare operates within the healthcare information services and healthcare technology industries, with recurring subscription revenue serving as its primary revenue driver.
The company’s core offerings include provider and hospital intelligence, physician and claims data, commercial analytics, and workflow integration tools delivered through cloud-based software platforms. Definitive Healthcare has positioned itself as a healthcare-specific intelligence provider with broad proprietary datasets and integrated analytics capabilities that support customer acquisition and commercialization efforts across healthcare markets. Founded in 2011 and headquartered in Framingham, Massachusetts, the company expanded through organic product development and acquisitions before completing its initial public offering in 2021. Public disclosures, including SEC filings, indicate that the company’s growth strategy has focused on expanding data coverage, increasing platform integration, and broadening customer penetration across life sciences and healthcare services markets.
Business Operations
Definitive Healthcare primarily generates revenue through subscription-based access to its healthcare commercial intelligence platform and related data products. The company reports operations as a single segment but organizes offerings across several commercial solution areas, including provider intelligence, life sciences analytics, physician-level targeting, and claims-based market intelligence. Key products include healthcare provider databases, hospital and physician profiling tools, referral analytics, patient claims analytics, and sales engagement solutions designed for commercial teams in healthcare and life sciences organizations. The company maintains a largely recurring revenue model supported by annual subscription contracts and enterprise agreements.
The company operates principally in the United States, though its customer base includes multinational healthcare and life sciences companies with international operations. Definitive Healthcare controls proprietary healthcare datasets compiled from public, commercial, and licensed sources, integrating them into cloud-based analytics products. Strategic acquisitions have strengthened its data and analytics capabilities, including the acquisitions of Populi, AnalyticsIQ’s healthcare-related assets, and healthcare data businesses intended to expand claims analytics and provider intelligence functionality. The company also maintains technology integrations and partnerships with customer relationship management and sales workflow providers to improve interoperability with enterprise healthcare commercial systems.
Strategic Position & Investments
Definitive Healthcare’s strategic direction centers on expanding its healthcare commercial intelligence platform through broader data coverage, enhanced analytics, and deeper penetration into pharmaceutical and medical device markets. Company disclosures and investor materials indicate ongoing investment in artificial intelligence-enabled analytics, workflow automation, and data enrichment capabilities intended to improve customer targeting and market intelligence functions. Growth initiatives have also focused on increasing enterprise-scale customer relationships and expanding cross-selling opportunities across its existing client base.
The company has pursued acquisitions to strengthen proprietary datasets and analytical capabilities, particularly in provider intelligence, patient claims analytics, and healthcare market intelligence. Investments in cloud-based infrastructure and scalable analytics platforms support its strategy of maintaining high recurring revenue and long-term customer retention. Definitive Healthcare competes against healthcare data providers, market intelligence firms, and analytics vendors, and differentiates itself through integrated datasets and healthcare-specific commercial workflows. Public filings and earnings materials indicate that management continues to prioritize operational efficiency, platform enhancement, and expansion within the broader healthcare commercial analytics sector.
Geographic Footprint
Definitive Healthcare is headquartered in Framingham, Massachusetts, and primarily operates within the United States healthcare market. Its datasets and analytics products are heavily concentrated on U.S. hospitals, physicians, health systems, payers, and healthcare providers, reflecting the complexity and scale of the U.S. healthcare industry. The company maintains operational capabilities that support enterprise customers with national and multinational healthcare operations.
While the company’s direct geographic exposure outside the United States appears more limited compared with larger global healthcare information firms, its customer base includes organizations with operations across North America, Europe, and other international markets. Public disclosures indicate that international revenue represents a smaller portion of total revenue relative to domestic operations. Data regarding material standalone international operational infrastructure is inconclusive based on available public sources.
Leadership & Governance
Definitive Healthcare was founded by healthcare data and analytics professionals seeking to modernize healthcare commercial intelligence and provider analytics. The company operates under a corporate governance framework overseen by its board of directors and executive leadership team, with strategic emphasis on recurring revenue growth, data expansion, and customer retention. Management communications in public filings and investor presentations consistently emphasize scalable data infrastructure, healthcare market transparency, and long-term subscription growth.
Key executives include:
- Jason Krantz – Founder and Chief Executive Officer
- Rick Booth – Chief Financial Officer
- Matt Sullivan – President
- Tom Godin – Chief Corporate Development Officer
- Mark Cunningham – Chief Technology Officer
- Sandi O’Meara – Chief Customer Officer
The leadership team has emphasized expansion of healthcare data assets, investment in analytics technologies, and strengthening enterprise customer relationships as central components of the company’s strategic vision, according to company earnings calls, investor presentations, and SEC filings.